These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 19920765

  • 1. Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice.
    Van Tassell BW, Varma A, Salloum FN, Das A, Seropian IM, Toldo S, Smithson L, Hoke NN, Chau VQ, Robati R, Abbate A.
    J Cardiovasc Pharmacol; 2010 Feb; 55(2):117-22. PubMed ID: 19920765
    [Abstract] [Full Text] [Related]

  • 2. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
    Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A.
    Circulation; 2008 May 20; 117(20):2670-83. PubMed ID: 18474815
    [Abstract] [Full Text] [Related]

  • 3. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ, Ding WH, Gao W, Huo Y, Hong T, Zhu RY, Ma DL.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):548-53. PubMed ID: 15144587
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L, Dong L, Chen X, Zhang L, Xu X, Ferro A, Xu B.
    Circulation; 2009 Sep 01; 120(9):764-73. PubMed ID: 19687354
    [Abstract] [Full Text] [Related]

  • 5. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A, Hu K, Bayer B, Wagner H, Ertl G, Bauersachs J, Frantz S.
    Basic Res Cardiol; 2007 Jul 01; 102(4):334-40. PubMed ID: 17340057
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL, Yin H, Huang J.
    Cardiovasc Pathol; 2007 Jul 01; 16(4):221-30. PubMed ID: 17637430
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.
    Straino S, Salloum FN, Baldi A, Ockaili RA, Piro M, Das A, Qureshi IZ, Biasucci LM, Capogrossi MC, Biondi-Zoccai GG, Severino A, Mellone P, Crea F, Vetrovec GW, Kukreja RC, Abbate A.
    J Cardiovasc Pharmacol; 2007 Nov 01; 50(5):571-7. PubMed ID: 18030068
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
    Obana M, Maeda M, Takeda K, Hayama A, Mohri T, Yamashita T, Nakaoka Y, Komuro I, Takeda K, Matsumiya G, Azuma J, Fujio Y.
    Circulation; 2010 Feb 09; 121(5):684-91. PubMed ID: 20100971
    [Abstract] [Full Text] [Related]

  • 9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1679-89. PubMed ID: 15489104
    [Abstract] [Full Text] [Related]

  • 10. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization.
    Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, Zhou R, Ben J, Xu Y, Chen Q.
    Basic Res Cardiol; 2011 Nov 19; 106(6):1311-28. PubMed ID: 21769674
    [Abstract] [Full Text] [Related]

  • 11. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y, Fukuda N, Yokoyama S, Kusumi Y, Hagikura K, Kawano T, Takayama T, Matsumoto T, Satomi A, Honye J, Mugishima H, Mitsumata M, Saito S.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):98-106. PubMed ID: 16979158
    [Abstract] [Full Text] [Related]

  • 12. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
    Ren J, Zhang S, Kovacs A, Wang Y, Muslin AJ.
    J Mol Cell Cardiol; 2005 Apr 07; 38(4):617-23. PubMed ID: 15808838
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic inhibition of phosphoinositide 3-kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice.
    Seropian IM, Abbate A, Toldo S, Harrington J, Smithson L, Ockaili R, Mezzaroma E, Damilano F, Hirsch E, Van Tassell BW.
    J Cardiovasc Pharmacol; 2010 Dec 07; 56(6):651-8. PubMed ID: 20881611
    [Abstract] [Full Text] [Related]

  • 14. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F, Smeets MB, O'Neill LA, Keogh B, McGuirk P, Timmers L, Tersteeg C, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP.
    Circulation; 2010 Jan 05; 121(1):80-90. PubMed ID: 20026776
    [Abstract] [Full Text] [Related]

  • 15. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
    Maekawa Y, Mizue N, Chan A, Shi Y, Liu Y, Dawood S, Chen M, Dawood F, de Couto G, Li GH, Suzuki N, Yeh WC, Gramolini A, Medin JA, Liu PP.
    Circulation; 2009 Oct 06; 120(14):1401-14. PubMed ID: 19770394
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
    Abbate A, Kontos MC, Grizzard JD, Biondi-Zoccai GG, Van Tassell BW, Robati R, Roach LM, Arena RA, Roberts CS, Varma A, Gelwix CC, Salloum FN, Hastillo A, Dinarello CA, Vetrovec GW, VCU-ART Investigators.
    Am J Cardiol; 2010 May 15; 105(10):1371-1377.e1. PubMed ID: 20451681
    [Abstract] [Full Text] [Related]

  • 17. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F, Combes S, Leal-Sanchez J, Barrère C, Cransac F, Sportouch-Dukhan C, Gahide G, Serre I, Kupfer E, Richard S, Hueber AO, Nargeot J, Piot C, Barrère-Lemaire S.
    Circulation; 2007 Dec 04; 116(23):2709-17. PubMed ID: 18025529
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I.
    Circulation; 2003 Dec 09; 108(23):2905-10. PubMed ID: 14656915
    [Abstract] [Full Text] [Related]

  • 19. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
    Zaidi SH, Huang Q, Momen A, Riazi A, Husain M.
    J Am Coll Cardiol; 2010 Jan 12; 55(2):135-43. PubMed ID: 20117381
    [Abstract] [Full Text] [Related]

  • 20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 12; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.